‘Inactivated low pathogenic avian influenza (H9N2) vaccine for chickens’, developed by the scientists of ICAR- National Institute of High Security Animal Diseases (ICAR-NIHSAD), Bhopal was transferred to Globion India, Secunderabad; Venkateshwara Hatcheries, Pune; Indovax, Gurgaon and Hester Biosciences, Ahmedabad on Tuesday, facilitated by Agrinnovate India (AgIn) at the National Agriculture Science Complex (NASC), New Delhi.
Speaking at the occasion of the technology transfer of the H9N2 vaccine for chickens, Dr. Himanshu Pathak, Secretary, Department of Agricultural Research (DARE) & Director General, Indian Council of Agricultural Research (ICAR), appreciated the efforts of the ICAR-NIHSAD scientists in the development of the indigenous vaccine for H9N2 virus and commended the Agrinnovate India (AgIn) for the efforts in the transfer of the technology to the industry.
You may also like to read: ICRISAT intern wins top award in the US for developing bio-insecticide
Dr. Bhupendra Nath Tripathi, Deputy Director General – (Animal Science), ICAR, asserted that the vaccine would meet the standard of the market both in India and abroad. The vaccine will contribute significantly to increasing the income of poultry farmers by reducing the economic loss due to the disease.
The event was further attended by Dr. Praveen Malik, CEO, Agrinnovate India; Dr. Aniket Sanyal, Director ICAR-NIHSAD, representatives of commercial firms, and other officials from ICAR and AgIn.
Source: Government of India
